‘In the weeds’: navigating the complex concerns, challenges and choices associated with medicinal cannabis consumption for endometriosis

Justin Sinclair, Allie Eathorne, Hannah Adler, Amelia Mardon, Millie Mardon, Orit Holtzman, Jason Abbott, Jerome Sarris, Mike Armour
Reproduction & fertility · 2025 · vol. 6(2) · doi:10.1530/raf-24-0098 · PMID:40445778 · PMC12164284 · W4410889842
article OA: gold CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This international survey found that most endometriosis patients use illicit cannabis for pain relief, viewing it as more effective than pharmaceuticals, but face concerns about legality, stigma, and lack of medical disclosure.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-08 ⓘ

This international, anonymous cross-sectional online survey recruited 889 people aged 18–55 with a medical diagnosis of endometriosis who used cannabis or phytocannabinoid products in the prior 3 months to manage endometriosis pain or related symptoms. The study found that illicit cannabis was the most common access pathway (56.7%), that most respondents planned to continue cannabis use and would recommend it to others (99% continuing; 90% recommending), and that inadequate pain control and medication side effects were the leading motivations for starting and continuing use; disclosure to medical professionals was also low among those using illicit cannabis. Key concerns included dependence/addiction fears, cost, stigma-driven judgment, potential legal consequences, and drug-driving law issues, and the authors note that illicit use and limited medical oversight raise concerns about potential drug interactions or withdrawal from reduced pharmaceutical medications. This paper is centrally about endometriosis — it investigates global drivers, barriers (especially stigma), and disclosure patterns related to medicinal cannabis consumption for endometriosis symptoms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract: People with endometriosis report consuming cannabis to manage their symptoms. Given the range of differing legalities and access pathways across the world, this study aimed to investigate the drivers and barriers to cannabis use worldwide. An online, anonymous, cross-sectional survey was distributed internationally by endometriosis organisations and was open to anyone consuming cannabis for endometriosis symptoms. Survey questions included motivations for both starting and ongoing cannabis consumption, concerns over cannabis use, reasons for stopping cannabis, and communication of cannabis consumption with healthcare providers. Eight hundred and eighty-nine responses were collected across >10 countries. Illicit cannabis (56.7%) was the most common access pathway. 99% of respondents stated they would continue to use cannabis to manage their endometriosis-based symptoms, with 90% reporting they would recommend its use to a friend or relative with the disease. The most common motivation(s) for cannabis consumption were inadequate pain control (68.6%) and bothersome side effects of medications (56.3%). Similar motivations were reported for ongoing cannabis consumption, with concerns over dependence/addiction on pharmaceutical medications (43.9%) being another common motivation. Those using illicit cannabis were significantly less likely (P < 0.0001) to disclose their cannabis consumption to medical professionals. Cannabis was viewed as superior to pharmaceuticals both in terms of effectiveness and side-effect profile. Despite this, concerns around cost, breaking the law, judgement due to stigma, and current drug-driving laws were reported. Illicit usage and lack of medical oversight raise concerns over potential drug interactions or withdrawal effects due to reduction in pharmaceutical medications because of cannabis. Lay summary: Survey participants reported that it is most common internationally for people using cannabis to manage endometriosis pain and associated symptoms to access this illegally, despite medical access being available in many countries. Many respondents also reported that cannabis was more effective and had a more tolerable side-effect profile than pharmaceutical medications they had used previously. However, over half of respondents were concerned about the negative impact of stigma associated with cannabis and how this might affect their day-to-day lives. Other concerns were potentially breaking the law where they live, possibly losing their driving licence due to drug-driving laws, or losing their job due to workplace drug-testing policies. Such concerns may be why more than 30% of participants reported not disclosing their cannabis consumption to their doctor. This is concerning because medical supervision is important to monitor for side effects and potential drug interactions, which people using cannabis may not know exist.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Medical Marijuana Medical Marijuana

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (65)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-06-01T00:31:26.287653+00:00
License: CC0 · commercial use OK